{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Aiken",
      "state": "SC",
      "country": "United States",
      "classification": "Class III",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "67800",
      "recalling_firm": "GlaxoSmithKline Consumer Healthcare; dba-GlaxoSmithKline",
      "address_1": "65 Windham Blvd",
      "address_2": "N/A",
      "postal_code": "29805-9384",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "U.S. Nationwide",
      "recall_number": "D-1247-2014",
      "product_description": "Nicorette Lozenge and NicoDerm CQ, nicotine polacrilex system. 189 2mg Mint Flavored Lozenges + 21 31 mg Patches. OTC Only.  GlaxoSmithKlein, 1000 GSK Drive, Moon Township, PA 15108.  UPC: 0-03-0766-1480-30-2.",
      "product_quantity": "150 cases",
      "reason_for_recall": "Failed Lozenge Specifications; Lozenges are overly thick, overly soft, and sub and superpotent.",
      "recall_initiation_date": "20140220",
      "center_classification_date": "20140418",
      "termination_date": "20170120",
      "report_date": "20140430",
      "code_info": "Lot #13L05N, Expiry: 8/15",
      "more_code_info": ""
    }
  ]
}